1van Venrooij GE, Eckhardt MD, Boon TA . Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia [J].Urology, 2004, 63(3):476-480.
2van Venrooij GE, Boon TA. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis[J]. J Urol, 1996, 155(6):2014-2018.
3Steele GS, Sullivan MP, Sleep DJ, et al. Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms[J].J Urol, 2000, 164(2) : 344-348.
4Gotoh M, Yoshikawa Y, Kondo AS, et al. Prognostic value of pressure-flow study in surgical treatment of benign prostatic obstruction[J]. World J Urol, 1999, 17(5) :274-278.
5Abrams P. In support of pressure-flow studies for evaluating men with lower urinary tract symptoms[J]. Urology, 1994, 44(2) :153-155.
6KaplanSA,OlssnCA.TheAmericanUrologyAssociationsymptomscoreintheevaluationofmenwithlowerurinarytractsymptoms:at2yearsoffollowup .Doesitwork ?[].The Journal of Urology.1996
7Jerry GB.Obstruction uropathy in male[].Urologic Clinics of North America.1996
8Ameda K,Koyanagi T,Nantani M,et al.The relevance of preoperative cyctometrography in patients with benign prostatic hyperplasia: correlating the findings with clinical features and outcome after prostatectomy[].Journal d Urologie.1994
9Koch WFRM,EL Din KE,de Wildt MJAM,et al.The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia[].Journal d Urologie.1996
10Wein AJ.Assessing treatment results in benign prostatic hyperplasia[].Urologic Clinics of North America.1995
4Matsuda T, Fujime M, Suda K. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia [ J ]. Anal Quant Cytol Histol, 2006 ;28 (3) : 121-4.
5Bravi F, Bosetti C, DalMaso L, et al. Food groups and risk of benign prostatic hyperplasia[J].Urology ,2006 ;67 ( 1 ) :73-9.
6Marks LS, Roehrbom CG, Wolford E, et al. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone Index in predicting treatment response [ J]. J Urol,2007 ; 177(4) :1408-13.
7Agrawai CS, ChMise PR, Bhandan BB. Correlation of prostate volume with intimation prostate symptom scorn and quality of life in menvvith benign prostatic hyperplasia [J]. Nepal Med Coil ],2008,10 (2): 104-107.
8MatsudaT, FujimeM, SudaK. Relationshipbetweentheprosta-tictis-suecomponents and natural history of benign prostatichy -perplasia [J]. Anal Quant Cytol Histol, 2009,28 (3): 121-124.
9RowhrbormCG, McConnellJD. Etiology, pathophysiology, ep -idemiology and natural history of benign prostatic hyperplasia [ M ]. Campbells Urology. Edited by Walsh PC, Retik AB, Vaughan EDJr, et al. PA; W. B. Saunders Company, 2011: 1297-1330.
10BraunMH, SonmerF, Haupt G, et al. Lower urinary tract symptoms and erectile dysfunction : CO一morbidity or typical aging malesymptoms: suits of the cologne male survey [J]. Eururol, 2009f 44 (5); 588-594.
